IME Technologies Moves to New, Larger R&D and Production Facility in The Netherlands

Medical technology company IME Technologies, developer, producer and scientific partner in the field of biomedical electro spinning processes and equipment, has moved its operations from Geldrop to a significantly larger facility in Waalre, The Netherlands. IME’s state-of-the-art technology enables scientists to develop medical implants that help the human body to repair itself, such as heart valves, blood vessels, nerves, tendons, skin and bone. IME is considered a world leader in this field.

Later this year (September 2018) IME Technologies will officially open the new facility during an event themed “the future of regenerative medicine.”
 
In the new IME building at the Van Dijklaan in Waalre, the company will have the ability to, according to the highest standards, not only produce its electro spinning machines autonomously, but also the actual extracellular matrices or scaffolds for the intended medical implants. These are developed by IME in close collaboration with various partners. The company has a growing number of customers and partners worldwide in industry, science and medical institutes.
 
IME’s technological solutions are able to mimic the natural human extracellular matrix for implants in the human body in nanometer format, applying specific polymers. Human cells attach to this matrix leading to new body tissue. This is in contrast to implants of traditional structures, which are seen as foreign and therefore can be rejected or lead to scar tissue.
 
IME Technologies develops and implements electro spin processes and equipment for the manufacturing of medical devices for (regenerative) medicine. Electro spinning is a flexible process for producing extremely thin fibres and structures that have excellent properties for use in regenerating human tissue. IME Technologies has developed unique electro spin technology for the reproducible and scalable production of electro spun material under medical conditions. Customers include industry, scientists and institutions.
 
Shareholders in the company are Dutch economic development firm De Brabantse Ontwikkelings Maatschappij and informal investor network TIIN Capital.